September 25, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Granted CE IVD Mark for Sample Collection Devices

SAFE AND RELIABLE SAMPLE PRESERVATION AT AMBIENT TEMPERATURE FOR IVD APPLICATIONS Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices. IRVINE, Calif., (Sept. 25, 2020) — Zymo Research announced that three of its DNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection... Read more

September 22, 2020 Life Science Tools Product Launch

BioTtechne Announces Commercial Release of New Co-detection Assays for Simultaneous Detection of RNA and Protein on the Same Sample

Expanding Bio-Techne’s lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS, Sept. 22, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables... Read more

September 17, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership

MINNEAPOLIS, Sept. 17, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products.   The agreement grants QIAGEN a non-exclusive development license to Bio-Techne’s exosome... Read more

September 16, 2020 Life Science Tools M&A, Partnerships Mass Spectrometry

Fluidigm Joins Global Consortium of Cancer Prevention Experts

CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies Principal Focus on Advancing Understanding of Breast and Skin Cancer Risks SOUTH SAN FRANCISCO, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a... Read more

September 16, 2020 Clinical Research/Diagn. Life Science Tools Liq. Handling & Robotics Microscopy

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

Hilden, Germany and Ann Arbor, Michigan, September 17, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology.... Read more

September 16, 2020 Chemicals, Reagents & Kits Life Science Tools Product Launch

Targeted sequencing with Oxford Nanopore: Fast, flexible, PCR-free Cas9 Sequencing Kit now available in store

Wed 16th September 2020 New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with nanopore enables fast, simple, flexible target enrichment of long regions of interest – read lengths of over 100 kb have been observed to date. The approach is amplification-free, opening up regions... Read more

September 14, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test

 Fill Up Your Sanger Sequencers & Test to Capacity ANN ARBOR, Mich, (September 29th, 2020) Swift Biosciences, a leader in Next-Generation Sequencing Manufacturing & Technology and BillionToOne, a precision diagnostics company today announced that Swift Bioscience will be the exclusive distributor of BillionToOne’s RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity... Read more

September 9, 2020 Life Science Tools Product Launch

PCR Biosystems launches RiboShield™ RNase Inhibitor to ensure reliable RNA protection

Caption: RiboShield™ RNase Inhibitor. Click images to download.  London, UK (09 September 2020) — PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a... Read more

September 8, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a... Read more

August 25, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19

Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System Demonstrated 100 Percent Agreement with Authorized Nasopharyngeal Assays SOUTH SAN FRANCISCO, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight,... Read more